8-K - Bicara Therapeutics Inc. Common Stock | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 12, 2026, Bicara Therapeutics Inc. issued a press release entitled “Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 202

Other Event

9.01

Financial Statements and Exhibits (d) The following exhibits are being filed herewith: Exhibit No. Description 99.1 Press Release, dated January 12, 2026. 104 C

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1